Drugs / Ginkgo biloba extract 50
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT06495476 Comparator | Sep 2024 → Dec 2025 overdue | cognitive impairment with or without cerebellar ataxia | Beijing Tiantan Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ginkgo biloba extract 50 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06495476 ↗ |
| Route | Oral | “Ginkgo biloba extract 50 dropping pills, oral administration, 8 dropping pills /time, 3 times/day” NCT06495476 ↗ |